红日药业：股东及部分高管拟合计减持不超1.5757%公司股份

Core Viewpoint - Hongri Pharmaceutical (300026) announced that shareholder Yao Xiaoqing plans to reduce holdings by up to 46.9363 million shares, representing 1.5624% of the total share capital [1] Shareholder Reduction Plans - Yao Xiaoqing, holding 10% of the shares, intends to reduce holdings through centralized bidding or block trading, with a maximum reduction of 46.9363 million shares [1] - Senior management member Chen Ruiqiang, holding 0.0226% of the shares, plans to reduce holdings by up to 169,000 shares, representing 0.0056% of the total share capital [1] - Senior management member Zhang Kun, holding 0.031% of the shares, plans to reduce holdings by up to 232,000 shares, representing 0.0077% of the total share capital [1]